Fair point – isn’t that the best time to go aggressive on acquisition – just from timing perspective.
Co was particular on harping on the point of acquisition during H2 21 (specifically highlighting timing) for last acquistion.
One positive seems ESOP price which is fair to investors – unlike many other cos they are not using RSU at huge discounts – grant price is mkt price.
QIP price
Might be wrong here with limited understanding, but QIP is supposed to be a formulae driven – which comes to similar levels as current price. Wouldn’t co had some sort of price discovery among interested parties before announcing this path?
| Subscribe To Our Free Newsletter |
